Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi
- PMID: 9529074
- PMCID: PMC108081
- DOI: 10.1128/IAI.66.4.1507-1512.1998
Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi
Abstract
The serious morbidity associated with Lyme borreliosis has focused considerable effort on the development of a comprehensive vaccine for protection against infection with Borrelia burgdorferi. Induction of borreliacidal antibody by vaccination or infection has been shown to correlate with protection of humans and animals against infection with the Lyme spirochete. In this report, we showed that high levels of borreliacidal antibody (titer of 1,280) were produced in vitro when T and B cells from hamsters 14 days after vaccination were incubated with macrophages and B. burgdorferi. By contrast, T and B cells from hamsters 7 or 21 days after vaccination failed to initiate production of borreliacidal activity. Furthermore, the T cells from hamsters 7 or 21 days after vaccination inhibited the in vitro production of borreliacidal antibody when cocultured with T and B cells obtained from hamsters 14 days after vaccination. When cell-free supernatants from the suspensions of T and B cells from hamsters 14 days after vaccination were absorbed with recombinant OspA, they lost nearly all borreliacidal activity. The removal of anti-OspA antibody resulted in a decrease in borreliacidal titer from 1,280 to less than 4. These results demonstrate that T cells from vaccinated animals can prevent a sustained production of protective borreliacidal antibody.
Figures



Similar articles
-
Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine.J Infect Dis. 1996 Oct;174(4):739-46. doi: 10.1093/infdis/174.4.739. J Infect Dis. 1996. PMID: 8843211
-
Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.Infect Immun. 2000 Oct;68(10):5496-501. doi: 10.1128/IAI.68.10.5496-5501.2000. Infect Immun. 2000. PMID: 10992445 Free PMC article.
-
Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.Clin Diagn Lab Immunol. 2002 Sep;9(5):1095-101. doi: 10.1128/cdli.9.5.1095-1101.2002. Clin Diagn Lab Immunol. 2002. PMID: 12204965 Free PMC article.
-
A recombinant vaccine for Lyme disease.Behring Inst Mitt. 1994 Dec;(95):106-8. Behring Inst Mitt. 1994. PMID: 7755503 Review.
-
Vaccination as a modality to prevent Lyme disease. A status report.Infect Dis Clin North Am. 1999 Mar;13(1):135-48, vii. doi: 10.1016/s0891-5520(05)70047-7. Infect Dis Clin North Am. 1999. PMID: 10198796 Review.
Cited by
-
Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17.J Immunol. 2009 Nov 1;183(9):5644-53. doi: 10.4049/jimmunol.0901499. J Immunol. 2009. PMID: 19843949 Free PMC article.
-
Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.Clin Diagn Lab Immunol. 2004 Jan;11(1):35-41. doi: 10.1128/cdli.11.1.35-41.2004. Clin Diagn Lab Immunol. 2004. PMID: 14715542 Free PMC article.
-
Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species.Clin Vaccine Immunol. 2008 Aug;15(8):1199-207. doi: 10.1128/CVI.00129-08. Epub 2008 Jun 25. Clin Vaccine Immunol. 2008. PMID: 18579699 Free PMC article.
References
-
- Aberer E, Brunner C, Suchanek G, Klade H, Barbour A, Stanek G, Lassmann H. Molecular mimicry and Lyme borreliosis: shared antigenic determinant between Borrelia burgdorferiand human tissue. Ann Neurol. 1989;26:732–737. - PubMed
-
- Asbrink E, Hovmark A. Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis) Ann N Y Acad Sci. 1988;539:4–15. - PubMed
-
- Burgdorfer W, Lane R S, Barbour A G, Gresbrink R A, Anderson J R. The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg. 1985;34:925–930. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources